Ian Mortimer Insider Trades & Stock Holdings

PRESIDENT & CEO · Xenon Pharmaceuticals Inc. · Latest filing Sep 30, 2026

Ian Mortimer, PRESIDENT & CEO at Xenon Pharmaceuticals Inc. has 1 Form 4 trade on file since Sep 30, 2026. Open-market activity: 1 purchase ($1.12M) and 0 sales ($0), net +$1.12M. Latest filing: acquired 30K shares of $XENE on Sep 30, 2026 at $37.38.

Trades on file

1

Open-market bought

$1.12M

Open-market sold

$0

Net open-market

+$1.12M

Latest filing

Sep 30, 2026

All insider trades by Ian Mortimer

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Sep 30, 2026	$XENE	Buy (Open-market buy)	30K	$37.38	$1.12M			-2.1%			PRESIDENT & CEO		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Ian Mortimer traded

• $XENE

Frequently asked questions

Has Ian Mortimer been buying or selling stock?

Ian Mortimer has 1 open-market purchase and 0 open-market sales on file, net +$1.12M. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Ian Mortimer's latest insider trade?

acquired 30K shares of $XENE on Sep 30, 2026 at $37.38.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.